Forte Biosciences, Inc. · NASDAQ:FBRX
BVF PARTNERS L P/IL reported a 9.99% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
BVF PARTNERS L P/IL reported a 9.99% stake in Forte Biosciences, Inc., 643,622 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 643,622
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.30% | 338,860 |
| BVF I GP LLC | 5.30% | 338,860 |
| BIOTECHNOLOGY VALUE FUND II LP | 4.10% | 262,365 |
| BVF II GP LLC | 4.10% | 262,365 |
| Biotechnology Value Trading Fund OS LP | 0.50% | 30,882 |
| BVF Partners OS Ltd. | 0.50% | 30,882 |
| BVF GP HOLDINGS LLC | 9.30% | 601,225 |
| BVF PARTNERS L P/IL | 9.99% | 643,622 |
| BVF INC/IL | 9.99% | 643,622 |
| LAMPERT MARK N | 9.99% | 643,622 |
Source
Related
- Forte Biosciences, Inc.
- Bvf Partners L P
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Nov 14, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026